BARDA funds ZMapp-like Ebola drugs from Medicago, Fraunhofer

The Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services, has awarded contracts to biotech Medicago and nonprofit research and development firm Fraunhofer to make ZMapp-like Ebola drugs, the head of the agency revealed on 24 February.

More from Anti-infective

More from Therapy Areas